Drug firms urged to pay more attention to residues

Pharmaceutical companies are not doing enough to tackle the residues from their products found in waterways and even drinking water, according to an analysis of the drug and biotechnology sectors by sustainability ratings agency Oekom Research.

The full text of this article is only available to subscribers and free trialists. To login,please enter your email address and subscriber access code below.

Not a subscriber or free trialist? Why not take a free 14 day trial or subscribe today!

Having trouble logging in? Please contact our helpdesk

Back to top Back to top